CN Patent

CN106456631A — 利用短期饥饿方案结合激酶抑制剂来增强传统化学药物功效和可行性并逆转激酶在正常细胞和组织中的副作用

Assigned to University of Southern California USC · Expires 2017-02-22 · 9y expired

What this patent protects

一种减轻或治疗癌症症状和/或化疗或激酶抑制剂的作用的方法，包括鉴定患有癌症的受试者的步骤。在第一时间段内向受试者施用减少卡路里的膳食，所述减少卡路里的膳食每天提供最多1000千卡。向受试者施用激酶抑制剂。

USPTO Abstract

一种减轻或治疗癌症症状和/或化疗或激酶抑制剂的作用的方法，包括鉴定患有癌症的受试者的步骤。在第一时间段内向受试者施用减少卡路里的膳食，所述减少卡路里的膳食每天提供最多1000千卡。向受试者施用激酶抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number: CN106456631A
Jurisdiction: CN
Classification: —
Expires: 2017-02-22
Drug substance claim: No
Drug product claim: No
Assignee: University of Southern California USC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.